ARCHIVES

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry

October 11, 1996

FDA Discloses Avastin Regulatory History.

December 14, 2007

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005